Recombinant Human Albumin (rHSA): Definition, Production, and When to Use It Instead of Plasma HSA

What Is Recombinant Human Albumin (rHSA)?

Recombinant human albumin is the human albumin protein produced by recombinant DNA technology in a controlled expression system, then purified for research and biomanufacturing use. It is also called recombinant human serum albumin, recombinant HSA, or recombinant albumin. In product literature you will see the abbreviations rHSA and rhSA used interchangeably.

Albumin is the most abundant protein in mammalian blood serum. In cell culture and formulation workflows, it supports binding and transport of lipids, ions, and small molecules, helps maintain colloidal and osmotic balance, and contributes antioxidant capacity through its free thiol. Those functions make albumin a common component in serum-free media, cell processing buffers, cryopreservation mixes, and biologic or vaccine formulations.

Historically, laboratory and process albumin often came from bovine serum (BSA) or from human plasma donations (plasma-derived HSA). Advanced therapies and defined biomanufacturing processes increasingly prefer human-sequence albumin from a non-plasma source so teams can reduce reliance on blood-derived raw materials and tighten lot consistency.

Searchers sometimes use the phrase “synthetic albumin” when they mean non-plasma albumin. Commercially, recombinant human albumin is a recombinant biologic protein. It is expressed and purified, not assembled as a small-molecule chemical. When you compare options, focus on recombinant versus plasma-derived source, purity grade, and whether the material is intended for culture supplementation or for excipient-oriented formulation work.

InVitria supplies a suite of recombinant human albumin products for those needs, including culture-oriented and excipient-oriented grades. Browse Cellastim S, Optibumin 20, Optibumin 25, and Exbumin after you read the chooser section below.

rHSA vs rhSA spelling

Both “rHSA” and “rhSA” appear in literature and commerce for recombinant human serum albumin. This page uses rHSA as the primary form and treats rhSA as an equivalent abbreviation.

Where Does Recombinant Human Albumin Come From?

Recombinant human albumin comes from expression of the human albumin gene in a production host, followed by purification. Unlike plasma-derived HSA, it is not fractionated from donated human blood. Unlike BSA, it is not purified from bovine serum.

InVitria manufactures recombinant albumin using its ExpressTec platform. Product pages describe a rice-based, plant expression system. Materials are positioned as animal-origin-free and blood-free, and are produced at an ISO 9001:2015 certified, cGMP-compliant facility in Junction City, Kansas, USA. That controlled manufacturing approach is intended to support supply scale and lot consistency for defined processes.

Plasma-derived HSA still appears in many legacy protocols because it is familiar and widely available. Teams evaluating a switch typically weigh documentation needs, animal-origin-free policies, adventitious-agent risk framing, and whether a recombinant grade fits the unit operation (media, wash, cryo, or final formulation). For supplier qualification packages, start with InVitria’s Certificate of Origin and Animal-Free TSE-BSE statement and request lot-specific Certificates of Analysis.

For a deeper narrative on blood-free sourcing, see Blood-free recombinant human albumin. For the broader regulatory shift toward animal-origin-free inputs, see Regulatory bodies’ shift to animal-origin-free solutions.

Plasma-Derived HSA vs Recombinant HSA

Plasma-derived HSA is purified from human plasma donations. Recombinant HSA is expressed recombinantly and can be supplied as an animal-origin-free, blood-free material with manufacturing controls designed for lot consistency. The right choice depends on process needs, documentation requirements, and whether your team is replacing plasma components in culture or formulation workflows.

Use the comparison below as an educational starting point, not as a claim that every recombinant grade is a validated drop-in for every plasma HSA protocol. Side-by-side process data still matters.

When plasma HSA may still appear: established filings, historical media recipes, or processes where change control cost currently outweighs the benefit of a switch.

When teams evaluate rHSA: serum-free or chemically defined media programs, closed-system cell therapy processing, cryopreservation development, viral vector adjacent steps, and biologic or vaccine formulation work where animal-origin-free and blood-free inputs are preferred.

This page does not claim clinical superiority of rHSA as a drug product. The discussion here is about raw-material, process, and documentation considerations for biomanufacturing teams.

For analytical context comparing Optibumin to plasma HSA themes, see Analytical characterization: Optibumin vs plasma HSA and Optibumin vs traditional albumin.

Key Applications in Cell Culture, Viral Vectors, Cryopreservation, and Formulation

Recombinant human albumin shows up across several unit operations. Match the grade to the job, then qualify in your own system.

Cell culture and biomanufacturing

In serum-free and chemically defined media, albumin can support lipid delivery, antioxidant capacity, and culture performance for lines such as CHO, HEK293, hybridoma / NS0, Vero, and primary or stem cell types used in advanced therapy workflows. Lipid-enhanced culture grades are often evaluated when growth and productivity in defined media are the priority. See Antibody production with Cellastim supplementation for an application-note entry point.

Cell and gene therapy processing

Albumin is commonly evaluated in wash, hold, expansion support, and cryopreservation contexts for T cells, MSCs, HSCs, and iPSC-related workflows. High-purity liquid grades are often preferred when teams want defined, animal-origin-free inputs and closed-system-friendly formats. Related reading:

• Enhanced cryopreservation of T cells using Optibumin
• Low-DMSO cryopreservation of MSCs with Optibumin 25

Viral vector and vaccine associated uses

Depending on the process, albumin may be evaluated for culture support, filtration hold / filter passivation, or formulation stability around viral vectors and vaccines. Treat published notes as technical resources, not universal protocols. Start with Preserving lentiviral titer during sterile filtration and Exbumin: stabilizing virus with albumin to improve yield.

Formulation and excipient use

For biologic, vaccine, and advanced therapy formulation, teams look for recombinant albumin positioned for excipient-oriented documentation and quality systems. InVitria positions Exbumin for that lane and publicly notes regulatory precedent as a formulation component in an approved vaccine (ERVEBO).

Across all of these uses, review the SKU that matches your unit operation, then request a sample or CoA package through InVitria’s contact path.

Choosing the Right rHSA Grade: Culture vs Excipient

Not every recombinant albumin is interchangeable. Culture-oriented grades are developed for media supplementation and cell processing performance. Excipient-oriented grades are positioned for formulation and regulatory documentation needs. Match the grade to the unit operation and quality system, not only to the protein name.

Quick chooser

At a glance: InVitria rHSA products

Figures below summarize public hub / product positioning. Confirm lot specs on the CoA.

Always confirm with InVitria technical support and your QA requirements before locking a grade into a GMP process. Never assume a culture supplement is automatically qualified as an injectable excipient without the appropriate grade, documentation, and customer qualification.

Frequently Asked Questions

What is recombinant human albumin (rHSA)?

Recombinant human albumin is human albumin produced using recombinant DNA technology in a controlled expression system, then purified for research or biomanufacturing use. It is also called recombinant human serum albumin (rHSA or rhSA). Unlike plasma-derived HSA, it is not fractionated from donated human blood.

Where does recombinant human albumin come from?

rHSA comes from recombinant expression of the human albumin gene in a production host, followed by purification. InVitria manufactures recombinant albumin using its ExpressTec platform (described on product pages as a rice-based / plant expression system) in an animal-origin-free, blood-free process at its Kansas, USA facility. Always confirm lot-specific details on the Certificate of Analysis.

How is recombinant human albumin different from plasma-derived HSA?

Plasma-derived HSA is purified from human plasma donations. Recombinant HSA is expressed recombinantly and can be supplied as an animal-origin-free, blood-free material with manufacturing controls designed for lot consistency. Selection depends on process needs, documentation requirements, and whether a team is replacing plasma components in culture or formulation workflows.

Is recombinant albumin the same as “synthetic albumin”?

Searchers sometimes use “synthetic albumin” to mean non-plasma albumin. Scientifically, commercial rHSA is a recombinant biologic protein (expressed and purified), not a chemically synthesized small molecule. When comparing options, focus on recombinant vs plasma-derived source, purity grade, and intended use (culture vs excipient).

Can recombinant human albumin replace BSA in cell culture?

In many serum-free or chemically defined workflows, teams evaluate rHSA as a human-sequence alternative to bovine serum albumin (BSA). Suitability depends on the cell type, media design, and quality specifications. Review application data and perform process-specific qualification before a full switch.

What is the difference between culture-grade and excipient-grade rHSA?

Culture-oriented grades are developed for media supplementation and cell processing performance (for example, lipid-enhanced Cellastim S or high-purity Optibumin liquids for demanding workflows). Excipient-oriented grades (such as Exbumin) are positioned for formulation and regulatory documentation needs in vaccines, gene therapy, or biologic drug product contexts. Match the grade to the unit operation and quality system, not only to the protein name.

Which InVitria rHSA should I use: Optibumin, Cellastim S, or Exbumin?

As a starting guide: Cellastim S for lipid-enhanced cell culture supplementation; Optibumin 20/25 for ultra-high-purity liquid applications, including many cell therapy, cryopreservation, and conjugation / formulation research contexts (Optibumin 25 when a 25% liquid / closed-system fit matters); Exbumin when an excipient-focused recombinant albumin with InVitria’s published regulatory precedent messaging is required. Confirm with InVitria technical support and your QA requirements.

Is InVitria rHSA animal-origin-free?

InVitria positions its recombinant albumin products as animal-origin-free and blood-free, manufactured without animal- or human-derived components in the expression / production approach described on its product pages. Request the Certificate of Origin and Animal-Free / TSE-BSE statement for supplier qualification packages.

Why do biomanufacturers move away from plasma-derived albumin components?

Common drivers include reducing reliance on blood-derived raw materials, improving supply predictability, supporting animal-origin-free policies, and tightening lot-to-lot consistency for defined processes. The right substitute still requires analytical comparability and process validation in the customer’s system.

Can rHSA be used in AAV or lentiviral vector workflows?

Albumin is evaluated in multiple viral-vector-adjacent steps (for example, culture support, processing aids, filtration hold, or formulation stability) depending on the process. InVitria publishes application notes on topics such as lentiviral titer retention during filtration and virus yield / stabilization contexts. Treat those as technical resources, not universal protocols. Qualify in your own process.

What documentation is typically available for InVitria rHSA?

Typical packages referenced on invitria.com include Certificate of Analysis, Guidelines for Use, Safety Data Sheet, Certificate of Origin / Animal-Free TSE-BSE statement, and additional quality / regulatory support materials on request. Exact documents vary by SKU. Do not claim a DMF exists unless InVitria confirms the current status for that SKU in writing.

How should teams compare Optibumin 25 to 25% plasma HSA?

Optibumin 25 is positioned as a high-purity recombinant albumin liquid at the same nominal 25% concentration used for many plasma HSA workflows, including closed-system-oriented formats on the product page. Comparison work should include purity / impurity profile, additives / stabilizers, performance in the specific unit operation, and documentation needs. Use side-by-side process data rather than assuming drop-in equivalence without testing.

Next Steps / Related Resources

If you are evaluating recombinant human albumin as an alternative to plasma-derived HSA or BSA, start with the grade that matches your unit operation, then request a sample or CoA package.

• Cellastim S rHSA
• Optibumin 20
• Optibumin 25
• Exbumin rHSA excipient
• Blood-free recombinant human albumin
• Certificate of Origin and Animal-Free TSE-BSE statement

Talk with an InVitria scientist about plasma HSA replacement in your process when you are ready for technical support.